Carl Denny

VP, Regulatory Affairs at Abeona Therapeutics

Mr. Denny has over 20 years of experience in Chemistry Manufacturing and Controls (CMC) and regulatory affairs in the registration of gene therapies and mRNA products including AMONDYS 45 (casimersen) and AAV-based gene therapy Zolgensma® (onasemnogene abeparvovec-xioi). Carl has also served in multiple roles of increasing responsibility at Sarepta Therapeutics, Inc., AveXis, Inc., GE Healthcare, Takeda Pharmaceuticals, Catalent Pharma Services, Abbott Laboratories and Eli Lilly.

Location

Chicago, United States

Links

Previous companies


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Abeona Therapeutics

1 followers

Abeona Therapeutics (Nasdaq: ABEO) is a fully-integrated gene and cell therapy company at the forefront of the rapidly-advancing field of genetic medicine.


Industries

Employees

51-200

Links